Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Pathophysiology of vascular disease in diabetes: effects of gliclazide.

Colwell JA.

Am J Med. 1991 Jun 24;90(6A):50S-54S. Review.

PMID:
1872305
2.

[Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].

Lesobre B.

Journ Annu Diabetol Hotel Dieu. 1990:325-34. Review. French. No abstract available.

PMID:
2195215
3.
4.

Hemobiological properties of gliclazide.

Ziegler O, Drouin P.

J Diabetes Complications. 1994 Oct-Dec;8(4):235-9. Review.

PMID:
7833500
5.

Vascular benefits of gliclazide beyond glycemic control.

Jennings PE.

Metabolism. 2000 Oct;49(10 Suppl 2):17-20. Review.

PMID:
11078471
6.

Hemobiological activity of gliclazide in diabetes mellitus.

Ziegler O, Drouin P.

Diabetes Res Clin Pract. 1991;14 Suppl 2:S83-9. Review.

PMID:
1794271
7.

Vascular growth factors and the development of macrovascular disease in diabetes mellitus.

Koschinsky T, Bünting CE, Rütter R, Gries FA.

Diabete Metab. 1987 Jul;13(3 Pt 2):318-25.

PMID:
3308559
8.

Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.

Larkins RG, Jerums G, Taft JL, Godfrey H, Smith IL, Martin TJ.

Diabetes Res Clin Pract. 1988 Jan 7;4(2):81-7.

PMID:
3125029
9.

Sulfonylureas and platelet function.

Klaff LJ, Kernoff L, Vinik AI, Jackson WP, Jacobs P.

Am J Med. 1981 Mar;70(3):627-30. Review.

PMID:
6782875
10.

Do platelets have anything to do with diabetic microvascular disease?

Colwell JA, Winocour PD, Halushka PV.

Diabetes. 1983 May;32 Suppl 2:14-9. Review.

PMID:
6242836
12.

Pathogenesis of diabetic microangiopathy: an overview.

Barnett AH.

Am J Med. 1991 Jun 24;90(6A):67S-73S. Review.

PMID:
1872307
13.

Pathogenesis of atherosclerosis in diabetes mellitus.

Colwell JA, Lopes-Virella M, Halushka PV.

Diabetes Care. 1981 Jan-Feb;4(1):121-33.

PMID:
7009108
14.

New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.

Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV.

Am J Med. 1983 Nov 30;75(5B):67-80. Review.

PMID:
6424441
15.

Atherosclerosis in diabetes: the role of hyperinsulinemia.

Stolar MW.

Metabolism. 1988 Feb;37(2 Suppl 1):1-9. Review.

PMID:
3277013
16.

Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.

Renier G, Mamputu JC, Desfaits AC, Serri O.

J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):20-9.

PMID:
12623165
17.
18.

Gliclazide: metabolic and vascular effects--a perspective.

Alberti KG, Johnson AB, Taylor R.

Metabolism. 1992 May;41(5 Suppl 1):40-5. Review.

PMID:
1574015
19.

Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients.

Gram J, Jespersen J.

Metabolism. 1992 May;41(5 Suppl 1):25-9. Review.

PMID:
1574011
20.

Supplemental Content

Support Center